Agreed R - at a quickish read, very very lame. My take: plenty of drum banging but noone playing a tune yet. It's not as though we haven't been very patient.
And one small para re the US launch: 'continuing discusions' re commercial & tech issues ? What specifically? Are they nearing the end? I'd almost settle for a "progressing well".
On the +ve side, highlights were launch of Endo targeted for Q2 CY2025 and Oesoph Cancer target for Q1 CY 2025.
PIQ Price at posting:
91.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)